Newsroom
Pharmaceutical Plant News
Permits, awards, power agreements and policy from the projects we track, written up by the research desk and published as they land.
Yesterday, 18 November 2026
Biocon Secures European Commission Approval for Pertuzumab Biosimilar Pebrilzo in HER2-Positive Breast Cancer
Biocon's pertuzumab biosimilar Pebrilzo wins European Commission approval for HER2-positive breast cancer, the first under EMA's revised clinical pathway.
Nanoform Partners With European CDMO to Manufacture High-Concentration Biologics Under GMP in Germany
LOTTE Biologics Signs First Commercial Manufacturing Agreement for Songdo Plant 1 in South Korea
Johnson & Johnson Acquires Ollin Biosciences for $2.2 Billion to Advance Phase 3 Retinal Drug in the US
Merck KGaA to Acquire Rapid Micro Biosystemsn in All-Cash Deal
Biocon Secures US FDA Approval for Fifth Oncology Biosimilar, Pebrilzo
Seawolf Therapeutics Launches With $100 Million and Sanofi Partnership to Advance DNA-Based Medicines in the US
OBI Pharma and Novartis Partner to Develop Next-Generation ADC Therapies in Taiwan
HTL Biotechnology Opens $16.54 Million HTL8 Polynucleotide Purification Unit at Javené Site in France
Lilly Invests $3.5 Billion in Pennsylvania Drug Manufacturing Plant, Creating 850 Jobs
Pace Life Sciences Lands Role in Centillion-Led ARPA-H GIVE Award for RNA Medicine Manufacturing
Pfizer Secures Up to $1.5 Billion from Blackstone Life Sciences to Fund US Obesity Drug Berobenatide
HLB Pharmaceutical Starts $41.4 Million Tablet Plant in Hwaseong, South Korea
Orexo and SVF Vaccines Partner on AmorphOX-Based LNP-mRNA Vaccine Research in Sweden
UAE Regulator Emirates Drug Establishment Signs Viatris MOU to Localise Pharmaceutical Manufacturing
Curia Invests $5.61 Million in Precision Fermentation Facility in León, Spain, Expanding Capacity to 58,000 Liters
Pfizer Invests $650 Million in Groton Manufacturing Technology Center to Expand Clinical Trial Supply Production in Connecticut, US
Biocodex Invests $16.87 Million in Beauvais Live Biotherapeutics Manufacturing Facility Through MRM Health Partnership in France
CStone and Kimia Therapeutics Partner to Advance Potential First-in-Class DNA Damage Response Therapy for Solid Tumors in China and Australia
Teva Secures U.S. Rights to Two Samsung Bioepis Immunology Biosimilars Under 2026 Licensing Deal
Lonza to Acquire Merck's US CDMO Business Across Five Sites
Global Pharma Firm Expands AGC Biologics Partnership Across Denmark and Japan, Raising Deal Value Above $560 Million
Supernus Completes Indivior Merger to Form 11-Product CNS Pharmaceutical Company in the US
Glenmark’s 160,000-Square-Foot Allentown Distribution Center Supplies 321 Locations Across 43 US States
Terrestrial Bio Launches 40,000-Square-Foot Tacterra Microarray Patch Manufacturing Facility in Massachusetts, US
Cambrex Invests $120 Million to Expand Charles City Pharmaceutical Facility in Iowa, US Adding 160,000 Liters of Capacity
MilliporeSigma, subsidiary of Merck, Opens Bioprocessing Production Center Worth Over $335.75 Million in Daejeon, South Korea
Pharmadule Morimatsu Delivers AstraZeneca ADC Conjugation Modules From Suzhou, China, to Singapore in Under Six Months
Experic Secures HPRA Manufacturing and GMP Approvals for Kilbeggan Clinical Supply Facility in Ireland
Tillotts Pharma Plans $25.7 Million Investment to Acquire Haupt Pharma Wülfing in Gronau, Germany
Kier Resumes Pre-Construction Work on $4.70 Billion H50 High-Containment Facility in Harlow, UK
Idorsia Advances Daridorexant Into Autism Research After Phase 2 Trial Reveals Unexpected Functional Benefits in Switzerland
Sudeep Pharma's Nandesari Plant in Gujarat Clears US FDA Review
Pathos AI Teams Up With Bristol Myers Squibb and Tempus AI to Expand AI-Driven Neuroscience Research
LGM Pharma Expands GLP Bioanalysis and Impurity Testing Capabilities With Sannova Analytical Integration in New Jersey, US
IMUNON Strikes Up to $16.5 Million ThermoDox Licensing Deal With VoxelDox to Prioritize US Ovarian Cancer Program
ESTEVE CDMO Commits Over $80 Million to New 250 m³ Manufacturing Site in Shaoxing, China
DKSH Expands Healthcare Presence Across Middle East and North Africa With $390 Million NewBridge Pharmaceuticals Acquisition
Nouscom Secures $135 Million Series D Funding Backed by Lynch Syndrome Clinical Data Presented at ESMO in Switzerland
Cotecna and Energon Labs Expand Pharmaceutical Testing Capabilities in India Through Hyderabad Acquisition
Perceptive Discovery Teams Up With Atley Solutions to Expand At-211 Research Capabilities in US and UK
Taiwan's Jyong Biotech Files Plan for Texas Plant and U.S. Operations Center
Millicent Pharma Invests Millions in Larne Manufacturing Expansion, Creating 20 Jobs in UK
Callan JMB Secures $28 Million TRUKING Equipment Order for Atlas Complex Pharma Plant in Alabama, US
Bio-Techne Launches GMP Small Molecule Production at New 10,000-Square-Foot Cell Therapy Facility in Bristol, UK
ABIONYX Taps OLON for CER-001 Validation Batches at Two France Sites
Danaher Launches Autonomous AI Antibody Lab to Speed Discovery Eightfold
Piramal Pharma Solutions Commissions Microbiology Lab at $85 Million Lexington Expansion Site in Kentucky, US
Fujifilm Expands Japan ADC Manufacturing With New Linker-Payload Equipment at Fukushima Plant
Orion Pharma Invests Over $112 Million to Upgrade Four Finland Manufacturing Sites
Edinburgh CDMO RoslinCT Wins up to $9.59 Million Scottish Enterprise Grant for Digital Manufacturing Push
Hovione Invests $35 Million in Continuous Tableting Line at New Jersey, US Site
GE HealthCare to pay $945 Million in cash for PET radiopharmaceutical maker SOFIE Biosciences in US
Dunbar Pharma Plans 2027 API Manufacturing Expansion in Ireland
Kyrgyzstan Signs Memorandum for $1 Billion Pharmaceutical Industrial Park
BMK Pharma Set to Begin Interior Work on Allen Headquarters and Sterile Drug Production Site
Uttarakhand Governor Inaugurates J.K. Lifecare Centres' New API and Intermediates Manufacturing Facility in Ujjain, India
Live from the tracker
The projects behind these stories
Capacity, capex, stage, contractors and verified contacts for every project we track, updated daily.